BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:38 PM
Feb 02, 2017
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ASN003: Ph I started

Asana began an open-label, U.S. Phase I trial to evaluate ASN003 in about 100 patients. A dose-escalation part will determine the dose for the expansion cohort in the second part, which will...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >